Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AZ's high-powered Crestor could gain from payer limits on PCSK9 meds
AZ's high-powered Crestor could gain from payer limits on PCSK9 meds
AZ's high-powered Crestor could gain from payer limits on PCSK9 meds
Submitted by
admin
on September 11, 2015 - 9:55am
Source:
Fierce Pharma Marketing
News Tags:
AstraZeneca
Crestor
PCSK9 inhibitors
drug pricing
Repatha
Praluent
Amgen
Regeneron
Sanofi
Headline:
AZ's high-powered Crestor could gain from payer limits on PCSK9 meds
Do Not Allow Advertisers to Use My Personal information
